Abivax
Marcus Wilkes, Ph.D. has extensive experience in global market access and pricing in the pharmaceutical industry. Marcus has held leadership roles at various companies including Abivax, Cerevel Therapeutics, and Arena Pharmaceuticals. Prior to that, they worked as a Senior Engagement Manager at Precision Xtract and Insight Strategy Advisors. Dr. Wilkes also has experience in research and development as a Biology Intern at SuperGen. Additionally, they have a background in teaching as a Japanese Language Instructor at the LDS Missionary Training Center. Overall, Dr. Wilkes has a diverse range of experience in the pharmaceutical industry and a strong background in market access and pricing.
Marcus Wilkes, Ph.D. holds a Bachelor of Science (B.S.) degree in Molecular Biology from Brigham Young University. Marcus further pursued their education at Cornell University, where they earned a Doctor of Philosophy (PhD) degree in Pharmacology.
This person is not in any offices
Abivax
Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.